News & Events

Press Releases
January 6, 2017
Bristol-Myers Squibb Company (NYSE:BMY) and GeneCentric Diagnostics, Inc. today announced a biomarker research collaboration to explore whether the application of GeneCentric’s Cancer Subtype Platform (CSP™) might be able to identify translational biomarkers for Opdivo (nivolumab)…
May 18, 2016
GeneCentric to Present Data at the American Society of Clinical Oncology (ASCO) 2016 Annual Meeting
November 12, 2015
Dr. Myla Lai-Goldman discusses GeneCentric’s Cancer Subtyping Platform (CSP™) with Healtheo360’s David Duplay and Courtland Long
November 9, 2015
On January 26, 2016 at 2:00 pm, GeneCentric’s Hawazin Faruki will speak at the Personalized Medicine World Conference (PMWC) 2016 Silicon Valley on “Genomic Tumor Profiling – Advancing Beyond Gene Mutations.” PMWC…
September 4, 2015
GeneCentric Diagnostics, Inc., a company devoted to changing the taxonomy of cancer through an integrated analysis of tumor pathology and genomics, today announced that it will present new data on its lung cancer subtyping product, LSP™ 120, at the 16th World Conference on Lung Cancer being held September 6-9, 2015 at the Colorado Convention Center in Denver, CO.
April 28, 2015
On May 5, 2015, GeneCentric will present at the Southeast Investor & Venture Philanthropy Oncology Summit 2015. The Summit features more than 30 of the Southeast’s top private oncology companies. Attendees come…
March 2, 2015
GeneCentric is one of only 13 companies selected to participate at this year’s CED Life Science Conference Showcase. Dr. Myla Lai-Goldman, CEO of GeneCentric, will be presenting an overview of the company’s…
November 6, 2014
On November 15, 2014, at the annual Association of Molecular Pathology meeting in Maryland just outside Washington DC, GeneCentric presented a validation study of its Lung Cancer Gene Expression Subtyping Panel (LSP)…
Publications & Presentations
No results found.
No results found.